Differential RNA Transcriptome in Ustekinumab Responders vs Non-Responders
Journal of Drugs in Dermatology : JDD
|February 6, 2023
Abstract
None:
Despite numerous available psoriasis treatments, no "one size fits all" regimen provides complete disease control without side effects, logistical obstacles, and/or expense. Despite increasingly efficacious drugs, only 20-25% of patients treated with biologic therapies achieve completely clear skin (PASI 100) and even fewer achieve this if they have experienced failures of multiple biologics.
More Related Videos
12:54Real-time Analysis of Transcription Factor Binding, Transcription, Translation, and Turnover to Display Global Events During Cellular Activation
Published on: March 7, 2018
13.7K
10:15Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
Published on: April 13, 2017
8.0K